AstraZeneca

Company Overview

AstraZeneca is a global pharmaceutical company that develops, manufactures, and sells prescription medicines. It is headquartered in the U.K. and operates in more than 100 countries. It focuses on treatment areas with ongoing medical demand and long-term patient need.

AstraZeneca's core business areas are oncology, cardiovascular, renal and metabolic diseases, respiratory and immunology, and rare diseases. Oncology is the most significant contributor to revenue, supported by medicines for cancer treatment across multiple tumor types. In cardiovascular and metabolic care, it sells drugs for diabetes, heart failure, and kidney disease. Respiratory products include treatments for asthma and chronic lung conditions. The rare disease segment addresses conditions with limited treatment options.

Financial Highlights (FY 2025)

Company's Business Segments

• Product Sales : Product segment revenue includes sales of products by therapy area which mainly include Oncology, rare disease, Cardiovascular, Renal & Metabolism, respiratory & immunology, vaccines & immune therpies and other medicines.
• Alliance Revenue : Alliance Revenue includes income from the ongoing operation of collaborative arrangements related to sales made by collaboration partners. AstraZeneca to a share of gross profits, a share of royalties or revenues, which are occuring while the collaboration agreement remains in place.
• Collaboration Revenue : It includes collaborative agreements in which Group has out-licensed (sold) certain rights associated with products